|
시장보고서
상품코드
2026244
생체 보철 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용도별, 소재 유형별, 기술 분야별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Bioprosthetics Market Size, Share, and Growth Analysis, By Product Type, By Application, By Material Type, By Technology Focus, By End-User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 생체 보철 시장 규모는 2024년에 51억 2,000만 달러로 평가되었고, 2025년 56억 4,000만 달러에서 2033년까지 122억 달러로 확대될 전망이며, 예측 기간(2026-2033년)에 CAGR10.1%로 성장할 전망입니다.
바이오 프로스테틱 시장은 주로 인구통계학적 추세와 특히 고령층에서 심혈관 및 근골격계 질환의 유병률 증가에 의해 주도되고 있습니다. 바이오 프로스테틱스는 조직 유래 인공심장판막, 탈세포화 이식편과 같은 생체 유래 임플란트를 포함하며, 환자의 예후를 개선하고 만성질환 관리 비용을 절감할 수 있습니다. 탈세포화 기술과 경카테터 전달법의 발전으로 업계는 기계식 임플란트에서 생체적합성 임플란트로 전환하고 있으며, 이로 인해 고위험군 환자 접근성이 확대되고 있습니다. 조직공학 및 최소침습기술의 혁신으로 기기의 내구성이 향상되고 수술 위험이 감소하고 있습니다. 또한, 인공지능(AI)은 프로세스 자동화, 적합성 향상, 설계 주기 단축을 통해 환자 맞춤형 설계에 혁명을 일으키고 있습니다. 이러한 기술 및 생체 보철물과의 시너지 효과는 진화하는 환경 속에서 제조업체와 공급업체에게 큰 비즈니스 기회를 창출하고 있습니다.
세계 생체보철물 시장 성장 요인
세계 생체 보철물 시장의 성장은 의료 종사자 및 의료 시스템에서 생체 보철 장치의 수용도가 높아짐에 따라 주도되고 있습니다. 이는 주로 기존 대안에 비해 우수한 생체 적합성, 혈전증 위험 감소 및 전반적인 환자 결과 개선이 이루어졌기 때문입니다. 의료진이 이러한 임플란트의 지속적인 성능에 대한 신뢰와 더불어 환자가 후속 시술이 필요 없는 치료법을 선호하는 경향이 임플란트의 도입과 임상 현장 안착을 촉진하고 있습니다. 의료 기관이 합병증을 줄이고 환자의 삶의 질을 향상시키는 치료법을 점점 더 중요시함에 따라 다양한 전문 분야에서 생체 보철 솔루션에 대한 수요가 지속적으로 증가하고 있으며, 이는 제조, 공급망 강화 및 임상 교육에 대한 투자 확대로 이어져 시장 성장을 더욱 촉진하고 있습니다.
세계 바이오 프로스테틱 시장 성장 억제요인
세계 바이오 프로스테틱 시장은 엄격한 규제 승인 절차로 인해 제조업체와 개발자에게 많은 자원과 시간을 요구하는 까다로운 규제 승인 절차로 인해 심각한 문제에 직면해 있습니다. 이러한 임상 검증의 복잡성과 더불어 지역별로 상이한 규제 요건으로 인해 장기적인 안전성과 생체 적합성에 대한 강조가 필요하며, 이는 보다 보수적인 투자 접근 방식과 신중한 상업화 관행으로 이어지고 있습니다. 소규모 기업들은 규제 불확실성으로 인해 프로젝트를 재검토하거나 중단해야 하는 경우가 많으며, 대기업들은 컴플라이언스 비용 증가로 어려움을 겪고 있습니다. 이러한 상황은 전반적으로 혁신의 속도를 저해하고, 임상에서 사용할 수 있는 생체보철 솔루션의 다양성을 좁혀 궁극적으로 시장 성장을 제약하는 요인으로 작용할 수 있습니다.
세계 생체보철물 시장 동향
세계 바이오프로스테틱 시장은 환자 맞춤형 임플란트에 대한 수요 증가를 배경으로 개인 맞춤형 이식 전략으로 크게 변화하고 있습니다. 제조업체들은 점점 더 모듈식 설계와 맞춤형 소재를 채택하고 있으며, 임상의와의 긴밀한 협력을 통해 고유한 해부학적 및 기능적 요구사항에 맞는 임플란트 개발을 추진하고 있습니다. 바이오패브리케이션 기술의 발전으로 개별적인 사이즈 설정과 생체 활성 표면의 구현이 가능해져 생체와의 통합성을 높이고 재수술의 필요성을 최소화하고 있습니다. 이러한 추세는 맞춤형 생산, 병원과의 전략적 제휴, 그리고 기존의 가격 체계보다 임상 결과 향상과 환자의 전반적인 만족도를 우선시하는 가치 기반 제안에 초점을 맞춘 혁신적인 비즈니스 모델의 출현을 촉진하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 생체 보철 시장 규모 : 제품 유형별
세계의 생체 보철 시장 규모 : 용도별
세계의 생체 보철 시장 규모 : 소재 유형별
세계의 생체 보철 시장 규모 : 기술 분야별
세계의 생체 보철 시장 규모 : 최종사용자별
세계의 생체 보철 시장 규모 : 유통 채널별
세계의 생체 보철 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.05.11Global Bioprosthetics Market size was valued at USD 5.12 Billion in 2024 and is poised to grow from USD 5.64 Billion in 2025 to USD 12.2 Billion by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).
The bioprosthetics market is primarily driven by demographic trends and the rising prevalence of cardiovascular and musculoskeletal diseases, particularly among aging populations. Bioprosthetics include biologically derived implants like tissue heart valves and decellularized grafts, enhancing patient outcomes and lowering chronic disease management costs. The industry has shifted from mechanical to biocompatible implants, thanks to advancements in decellularization and transcatheter delivery methods, facilitating broader access for higher-risk patients. Innovations in tissue engineering and minimally invasive techniques are enhancing device longevity and reducing surgical risks. Furthermore, artificial intelligence is revolutionizing patient-specific design by automating processes, improving fit, and shortening design cycles. This synergy between technology and bioprosthetics is creating substantial commercial opportunities for manufacturers and suppliers within this evolving landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioprosthetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bioprosthetics Market Segments Analysis
Global bioprosthetics market is segmented by product type, application, material type, technology focus, end-user, distribution channel and region. Based on product type, the market is segmented into Allografts, Xenografts, Autografts and Others. Based on application, the market is segmented into Cardiovascular, Orthopedics, Plastic Surgery and Wound Healing and Others. Based on material type, the market is segmented into Biocompatible Polymers, Biological Tissues and Others. Based on technology focus, the market is segmented into AI-Enhanced Prosthetic Design, 3D Bioprinted Implants, Smart Prosthetics with Sensors and Others. Based on end-user, the market is segmented into Hospitals, Specialty Orthopedic and Prosthetic Centers, Research and Academic Institutes and Others. Based on distribution channel, the market is segmented into Direct Sales to Institutions, Medical Device Distributors, Online Healthcare Marketplaces and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Bioprosthetics Market
The growth of the global bioprosthetics market is being driven by the rising acceptance of bioprosthetic devices among healthcare professionals and systems, primarily due to their superior biocompatibility, reduced risk of thrombosis, and better overall patient outcomes compared to traditional options. Healthcare providers' confidence in the sustained performance of these implants, coupled with patients' preference for treatments that necessitate fewer follow-up procedures, promotes their acquisition and integration into clinical practice. As healthcare institutions increasingly emphasize therapies that mitigate complications and enhance patients' quality of life, the demand for bioprosthetic solutions continues to rise across various specialties, leading to greater investment in manufacturing, supply chain enhancements, and clinical education, further propelling market growth.
Restraints in the Global Bioprosthetics Market
The Global Bioprosthetics market faces significant challenges due to stringent regulatory approval processes that impose substantial resource and time demands on manufacturers and developers. These complexities in clinical validation, along with differing regional regulatory requirements, necessitate a strong emphasis on long-term safety and biocompatibility, leading to more conservative investment approaches and cautious commercialization practices. Smaller companies often reconsider or halt their projects owing to regulatory uncertainties, while established firms grapple with increased compliance costs. This situation collectively hampers the rate of innovation and narrows the variety of bioprosthetic solutions available in clinical settings, ultimately constraining market growth.
Market Trends of the Global Bioprosthetics Market
The global bioprosthetics market is experiencing a significant shift towards personalized implantation strategies, driven by the rising demand for patient-specific implants. Manufacturers are increasingly adopting modular designs and customizable materials, fostering close collaboration with clinicians to tailor implants to unique anatomical and functional requirements. Advances in biofabrication technology have paved the way for individualized sizing and biologically active surfaces, which enhance integration and minimize the need for revision surgeries. This trend is promoting the emergence of innovative business models focused on bespoke production, strategic hospital partnerships, and value-based propositions that prioritize improved clinical outcomes and overall patient satisfaction over traditional pricing structures.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Bioprosthetics Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Allografts
- Cartilage and Tendon Allografts
- Skin and Dental Allografts
- Xenografts
- Porcine Heart Valves
- Bovine Pericardium
- Autografts
- Others
Global Bioprosthetics Market Size by Application & CAGR (2026-2033)
- Market Overview
- Cardiovascular
- Orthopedics
- Plastic Surgery and Wound Healing
- Others
Global Bioprosthetics Market Size by Material Type & CAGR (2026-2033)
- Market Overview
- Biocompatible Polymers
- Polyethylene
- Polyketones
- Biological Tissues
- Others
Global Bioprosthetics Market Size by Technology Focus & CAGR (2026-2033)
- Market Overview
- AI-Enhanced Prosthetic Design
- 3D Bioprinted Implants
- Smart Prosthetics with Sensors
- Others
Global Bioprosthetics Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Specialty Orthopedic and Prosthetic Centers
- Research and Academic Institutes
- Others
Global Bioprosthetics Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Direct Sales to Institutions
- Medical Device Distributors
- Online Healthcare Marketplaces
- Others
Global Bioprosthetics Market Size & CAGR (2026-2033)
- North America (Product Type, Application, Material Type, Technology Focus, End-User, Distribution Channel)
- US
- Canada
- Europe (Product Type, Application, Material Type, Technology Focus, End-User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, Material Type, Technology Focus, End-User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, Material Type, Technology Focus, End-User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, Material Type, Technology Focus, End-User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Edwards Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Artivion (CryoLife)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Braile Biomedica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Labcor Laboratorios
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JenaValve Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aortech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Getinge
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Allergan (AbbVie)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RTI Surgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LeMaitre Vascular
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sydnexis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AutoTissue Berlin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Coloplast
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
